1. Home
  2. KRRO

as of 02-17-2026 3:46pm EST

$11.63
+$0.46
+4.12%
Stocks Health Care Biotechnology: Pharmaceutical Preparations Nasdaq

Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.

Founded: 2014 Country:
N/A
Employees: N/A City: CAMBRIDGE
Market Cap: 101.1M IPO Year: N/A
Target Price: $54.60 AVG Volume (30 days): 294.9K
Analyst Decision: Strong Buy Number of Analysts: 12
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: N/A EPS Growth: N/A
52 Week Low/High: $5.20 - $55.89 Next Earning Date: 01-01-0001
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): 145.97% Revenue Growth (next year): -67.79%
P/E Ratio: N/A Index: N/A
Free Cash Flow: N/A FCF Growth: N/A

AI-Powered KRRO Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 79.55%
79.55%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Latest Korro Bio Inc. News

KRRO Breaking Stock News: Dive into KRRO Ticker-Specific Updates for Smart Investing

All KRRO News

Share on Social Networks: